K-878
Constipation-predominant Irritable Bowel Syndrome (IBS-C)
Phase IIActive
Key Facts
Indication
Constipation-predominant Irritable Bowel Syndrome (IBS-C)
Phase
Phase II
Status
Active
Company
About Kissei Pharmaceutical
Kissei Pharmaceutical is a mid-sized, research-driven Japanese pharmaceutical company with a history spanning over 70 years. Its strategic focus lies in developing and marketing novel drugs for urological, nephrological, and metabolic disorders, while also engaging in licensing and collaborative partnerships to expand its portfolio. The company leverages its expertise in drug discovery and development to address unmet medical needs, with a commercial presence in Japan and through international partnerships. Its financial stability is supported by marketed products and a pipeline of clinical-stage candidates.
View full company profile